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Background: Performing open carpal tunnel release (oCTR) in an office-based procedure room setting (PR) decreases surgical costs when compared with the operating
room (OR). However, it is unclear if the risk of major medical, wound, and iatrogenic
complications differ between settings. Our purpose was to compare the risk of major
medical complications associated with oCTR between PR and OR settings.
Methods: Utilizing the MarketScan Database, we identified adults undergoing isolated oCTR between 2006 and 2015 performed in PR and OR settings. ICD-9-CM
and/or CPT codes were used to identify major medical complications, surgical site
complications, and iatrogenic complications within 90 days of oCTR. Multivariable
logistic regression was used to compare complication risk between groups.
Results: Of the 2134 PR and 76,216 OR cases, the risk of major medical complications was 0.89% (19/2134) and 1.20% (914/76,216), respectively, with no difference observed in the multivariable analysis (adjusted odds ratio [OR] 0.84; 95%
CI 0.53–1.33; P = 0.45). Risk of surgical site complications was 0.56% (12/2134)
and 0.81% (616/76,216) for the PR and OR, respectively, with no difference in the
multivariable analysis (OR 0.68; 95% C.I. 0.38–1.22; P = 0.19). Iatrogenic complications were rarely observed (PR 1/2134 [0.05%], OR 71/76,216 [0.09%]), which
precluded multivariable modeling.
Conclusion: These results support a similar safety profile for both the PR and OR
surgical settings following oCTR with similar pooled major medical complications, pooled wound/surgical site complications, and iatrogenic complications.
(Plast Reconstr Surg Glob Open 2021;9:e3685; doi: 10.1097/GOX.0000000000003685;
Published online 12 July 2021.)

INTRODUCTION

Carpal tunnel syndrome is the most common compressive neuropathy of the upper extremity. Over 500,000
carpal tunnel releases are performed each year within the
United States, with direct costs exceeding 2 billion dollars
annually.1,2 There has been an increasing emphasis within
healthcare to deliver more cost-effective and efficient
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surgical services while still maintaining the highest quality
of patient care.
Substantial literature within the field of hand surgery has
suggested that one effective method of surgical cost reduction is the utilization of a procedure room setting (PR),
rather than the operating room setting (OR) for minor procedures.3–13 Compared with the more traditional OR surgical
setting with full sterility utilizing regional or general anesthesia, office-based PR surgical settings for minor hand procedures use field sterility under pure local anesthesia with
lidocaine and epinephrine. Generally, a tourniquet is not
used in the PR setting. Open carpal tunnel releases (oCTR),
trigger finger release, de Quervain release, and other minor
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procedures are feasible using WALANT techniques (wideawake, local-only anesthesia, no tourniquet) in the PR setting, which has been proposed to improve the value of care
for patients.3–6,8,9,11,12,14–16 Specific to oCTR, direct costs may
range from four-fold9 to 30-fold3 greater for the OR, when
compared with the PR. In addition to utilizing the WALANT
technique, decreased medical consultation and testing with
utilization of the PR setting may further lead to lower preoperative and overall costs.13,14
Value of care is equivalent to the treatment outcome,
or level of improvement, per unit cost.17–20 Improving
clinical or functional outcomes while maintaining a comparable treatment cost increases the value of care within
orthopedic surgery. Additionally, lowering surgical costs
while maintaining clinical and functional outcomes also
improves the value of care. Utilizing a value-based payment model has expanded efforts to enhance the treatment outcomes and effectiveness of healthcare delivery
within the United States and to reduce avoidable costs.21
In addition to cost, other vital components in evaluating value of care include clinical and functional outcomes,
as well as safety and complication rates. However, there
remains a paucity of evidence as to the safety profile of utilizing the PR setting for oCTRs and how it compares to the
complication rate of utilizing the OR, which is the traditional setting for CTR surgery using regional, sedation, or
general anesthesia. A subjectively low postoperative complication rate has been reported for various hand surgeries
performed in the PR setting, although most do not specifically investigate complication profiles or specifically compare complication rates between PR and OR settings.3,4,6,11,22
Among studies evaluating PR complications, Leblanc et al
published a multicenter noncomparative study evaluating
postoperative infection rates following oCTR performed in
the PR setting.10 Although the results were promising, with
rates of 0.4% and 0% for superficial and deep infections,
other medical complications and iatrogenic complications
to neurovascular or tendon structures were not evaluated.
Other studies have attempted to address the PR surgical
setting safety by comparing complication rates between
PR and OR, reporting zero complications for both settings
among oCTR patients and low complication rates for trigger finger release patients.8,23 However, both of these studies were limited by small sample sizes and under-powering
for the purpose of drawing strong conclusions.24
The primary purpose of our study was to evaluate
our hypothesis that the risk of major medical complications associated with oCTR was similar between PR and
OR settings in a large, geographically-diverse populationbased cohort. Our secondary purpose was to evaluate the
hypothesis that following oCTR, the risk of surgical site
and iatrogenic complications (neurovascular or tendon
injury) are similar between PR and OR surgical settings.

METHODS
Definition of PR and OR Populations

In this prospective cohort study, individuals aged 18–
64 years who underwent oCTR surgery from 7/1/2006
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to 6/30/2015 were identified using the IBM MarketScan
Commercial Database. Due to the deidentification and
limited dataset of the MarketScan database, this study was
considered exempt by the University of Utah Institutional
Review Board and the Washington University in St. Louis
Human Resource Protection Office. Included in this
database is information regarding enrollment, medical
and outpatient pharmacy claims, data for dependents,
employees, and individuals with Consolidated Omnibus
Budget Reconciliation Act (COBRA) continuation covered by employer-sponsored and other commercial health
insurance plans. The MarketScan database is a prospective database that encompasses over 150 million patients
throughout the study’s duration, with information contributed by commercial health insurance plans and employers. Not included in the database are individuals 65 years
and older, uninsured individuals, workers’ compensation,
government-sponsored plans, and individuals with other
types of private insurance.
Using the current procedural terminology, fourth edition (CPT-4) code 64721 for oCTR coded by a provider,
we identified individuals undergoing oCTR from the
inpatient and outpatient medical claims files. A diagnosis of carpal tunnel syndrome using the International
Classification of Disease, ninth revision, clinical modification 354.0 (ICD-9-CM 354.0) on the claim line for the
procedure was required. To assess complications and
comorbidities, 180 days of medical insurance coverage
enrollment before surgery and 90 days following surgery
was required. The OR surgical setting was identified by
utilizing uniform billing codes to identify if the procedure
took place in the OR based on the revenue center code
for major OR services (0360, 0361). The PR surgical setting was identified on the surgeon claim line via a placeof-service code of 11 (in-office procedure). Additionally,
there was no associated OR revenue center code for OR/
ambulatory surgery services (0360, 0361, or 0490). There
was also no associated claim for general, regional, sedation, or nerve block anesthesia on the day of the surgery.
Persons with unrelated procedures on the date of
oCTR were excluded to compare outcomes in patients
with isolated oCTR depending on the surgical setting.
Unrelated procedures comprised a broad range of CPT-4
codes with the exception of iatrogenic-related procedures
and nerve block codes. To avoid excluding patients with
intraoperative complications that were treated during
the index oCTR surgery, we included procedures on the
oCTR date that were potentially related to address possible iatrogenic injuries.
The exclusions for our study are summarized
in Supplemental Digital Content 1. (See appendix,
Supplemental Digital Content 1, which displays Appendix
I: Summary of study exclusions. Appendix II: Coding used
to identify and exclude noniatrogenic injuries. Appendix
III: Coding used to identify major medical complications.
Appendix IV: Coding used to identify surgical wound
complications. Appendix V: Coding used to identify iatrogenic surgical complications. Appendix VI: Summary
and comparison of comorbidities for PR and OR groups.
http://links.lww.com/PRSGO/B707.)
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Fig. 1. Illustration of relative risks/odds ratios for pooled major medical complications and surgical site
complications between procedure room and operating room settings. Note that there is no statistical difference between adjusted pooled major medical and adjusted pooled surgical site complication
risks between procedure room and operating room settings.

We included only the initial procedure that met qualification requirements for patients who had multiple oCTR
procedures during the study interval. We excluded individuals with noniatrogenic injuries (eg, rupture, injury to
the nerves/vessels/tendons associated with oCTR, open
wound) (SDC1: Appendix II, http://links.lww.com/
PRSGO/B707) that occurred within 30 days before surgery. In addition, oCTR procedures in persons coded for
a related surgery in the 180 days before the oCTR date,
suggesting that the oCTR was secondary to the prior
procedure, were excluded. To focus on nonemergent,
uncomplicated oCTR procedures, we excluded any procedures associated with an emergency department visit or
during an inpatient admission.
Identification of Underlying Comorbidities and Other
Potential Risk Factors for Complications

We utilized the Elixhauser classification to identify
comorbidities.25,26 Facility coding in one or more inpatient hospitalization and/or 2 or more outpatient claims
spaced at least 30 days apart were required, excluding outpatient claims regarding alcohol abuse, tobacco
abuse, drug abuse, weight loss, or obesity.27 Active smoking status was identified using diagnostic coding (ICD-9
305.1, 649.0x).
Identification of Major Medical and Surgical Outcomes

The primary outcome of our study was any major
medical complications within 90 days following oCTR. All
medical complications of interest were acute events only.
Thus, a single code was necessary within 90 days of the
surgery. We determined major medical complications of
interest as ICD-9-CM diagnosis/procedure codes for any
of the following: respiratory failure, cardiac/respiratory
arrest, congestive heart failure exacerbation, acute myocardial infarction, acute deep vein thrombosis, acute pulmonary embolism (PE), acute renal failure, postoperative
shock, acute stroke, transient ischemic attack, and death

(specific coding provided in SDC1: Appendix III. http://
links.lww.com/PRSGO/B707).
We utilized ICD-9-CM diagnosis or CPT-4 codes for surgical
site complications. Such complications included any nonhealing wound, wound disruption, surgical site infection, hemorrhage complicating a procedure, hematoma, and seroma
(specific coding provided in SDC1: Appendix IV. http://
links.lww.com/PRSGO/B707). We defined iatrogenic complications as any new neurovascular or tendon structure injury
that was not previously coded within the 6 months pre-oCTR
but was diagnosed and/or surgically-treated within 90 days
post-oCTR (specific coding provided in SDC1: Appendix V.
http://links.lww.com/PRSGO/B707).
Statistical Methods

To determine factors associated with medical, surgical,
and iatrogenic complications, we utilized a multivariable
logistic regression. We used the location of the surgery
as the primary exposure forced in the model. Variance
inflation factors were utilized to assess the potential multicollinearity of independent variables. In the initial full
models, we included variables with a P value less than 0.2
in bivariate analysis or with clinical/biologic plausibility.
We defined a P value less than 0.1 as the threshold for
retention of all variables as they were removed in a stepwise backward manner. We compared the demographics
and complication rates between PR and OR groups using
Fisher’s exact test or chi-squared tests for binary variables
and Student’s t or Mann-Whitney U tests for continuous
variables.
A power calculation was performed utilizing the
observed ratio of OR to PR cases (35.7:1). To achieve 80%
power at a 95% confidence level, a total of 1488 PR patients
and 53,122 OR patients would be needed to discriminate
a difference of 0.75% for major medical complications
(0.75% versus 1.5%) on the two-tailed two-proportion test.
All statistical analyses were performed in SAS version 9.4
(Cary, N.C.), with P < 0.05 considered statistically significant.
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RESULTS

We identified 2,134 patients treated with isolated oCTR in
the PR, and 76,216 in the OR. Subjects were excluded under
the following conditions: lack of health insurance coverage in
the 180 days before index and/or the 90 days post procedure
(n = 83,131), presence of coding for a noniatrogenic injury
in the 30 days before oCTR (n = 2835), a related surgery in
the 180 days before the oCTR (n = 8526), another CPT code
in the surgical range on the oCTR date (n = 79,699), evidence of an ER visit on the oCTR date (n = 2914), oCTR performed after the date of admission in the inpatient setting
(n = 49), inability to determine performance in the OR or PR
(n = 114,606), and subsequent oCTR procedures
(n = 16,441). Of included subjects, the mean age was 50 ± 9
years, with 66.8% being women. Additional demographics
are provided in Table 1. Smoking status and the frequency
of comorbidities for PR and OR groups are shown in SDC1.
(See SDC 1: Appendix VI. http://links.lww.com/PRSGO/
B707.)
Major Medical Outcomes

The crude pooled risk of a major medical complication was 0.89% (19/2134) for the PR group and 1.20%
(914/76,216) for the OR group (P = 0.19; Table 2). There
was no significant difference in major medical complication risk based on the surgical setting in the multivariable
analysis (adjusted odds ratio 0.84 for PR versus OR; 95%
CI 0.53–1.32; P = 0.45). This is illustrated in Figure 1. In
contrast, hypertension, diabetes, drug abuse, anemia,
rheumatoid arthritis/collagen vascular disease, chronic
pulmonary disease, neurologic disorders, psychological
disorders/psychoses, hypothyroidism, older age, and male
gender were associated with a significantly increased risk
of a major medical complication (Table 3).
Surgical Outcomes

The crude pooled risk of surgical site complications was 0.56% (12/2134) for the PR group and 0.81%

(616/76,216) for the OR group (P = 0.21). The risk of surgical site complications for both settings are provided in
Table 4. In the multivariable analysis, no significant association existed between surgical setting and surgical site
complications (adjusted odds ratio 0.68 for PR versus OR;
95% C.I. 0.38–1.22; P = 0.19; Table 5). This is illustrated in
Figure 1. Factors associated with an increased risk of surgical site complications included chronic pulmonary disease, diabetes, obesity, psychological disorders/psychoses,
solid tumor, male gender, and smoking, while the north
central region of the United States (compared with the
South) was associated with a significantly lower risk of surgical site complications (Table 5).
The crude pooled risk of iatrogenic surgical complications was 0.05% (1/2134) for the PR group, and 0.09%
(71/76,216) for the OR group (P > 0.99 Fisher’s exact
test; Table 6). Multivariable modeling was precluded due
to the lack of adequate sample size secondary to the rarity
of iatrogenic surgical complications.

DISCUSSION

Our main finding was that oCTR performed in the PR
setting was associated with a low risk of pooled major medical complications that was similar to the rate observed
for patients treated in a traditional OR setting. Within 90
days of surgery, we observed that 0.89% of PR patients and
1.20% of OR patients suffered a major medical complication, which was not significantly different. In light of how
this study was powered, we conclude that the risk of major
medical complications for PR and OR settings are no different within a threshold of less than 0.75%. These findings suggest that performing oCTR in the PR setting is
safe and comparable to choosing the OR as the surgical
setting from a medical safety standpoint.
Although we could not identify a large comparative study comparing complication rates between PR
and OR settings, our results in regard to major medical

Table 1. Demographic Data
Variable
Age
18–39
40–49
50–59
60 and older
Anesthesia type
General or regional
Sedation
Local
Postoperative nerve block
Insurance type
HMO or POS with capitation
All other plan types
Region
Northeast
North Central
South
West
Residence type
Urban
Rural
Gender
Men
Women

PR (n = 2134)

OR (n = 76,216)

P

258 (12.09%)
538 (25.21%)
911 (42.69%)
427 (20.01%)

10,992 (14.42%)
19,819 (26.00%)
32,507 (42.65%)
12,898 (16.92%)

Reference
<0.001
<0.01
<0.001

0 (0.00%)
0 (0.00%)
2134 (100%)
0 (0.00%)

63,351 (83.12%)
100 (0.13%)
12,765 (16.75%)
2405 (3.16%)

NA
—
—
—

849 (39.78%)
1285 (60.22%)

8889 (11.66%)
67,327 (88.34%)

<0.001
—

239 (11.20%)
491 (23.01%)
519 (24.32%)
885 (41.47%)

12,433 (16.31%)
27,807 (36.48%)
28,068 (36.83%)
7908 (10.38%)

0.651
0.069
Reference
0.006

1536 (71.98%)
598 (28.02%)

55,198 (72.42%)
21,018 (27.58%)

0.65
—

717 (33.60%)
1417 (66.40%)

25,275 (33.16%)
50,941 (66.84%)

0.672
—

Continuous variables were analyzed using logistic regression, and categorical variables were analyzed using the chi-squared test.
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Table 2. Unadjusted Risk of Major Medical Complications

Pooled major medical
complications
Acute MI
Acute stroke
TIA
Death
Cardiac/respiratory
arrest
Respiratory failure
Acute PE
Acute DVT
Congestive heart
failure exacerbation
Acute renal failure
Postoperative shock

PR
(n = 2134)

OR
(n = 76,216)

P*

19 (0.89%)
2 (0.09%)
12 (0.56%)
4 (0.19%)
0 (0.00%)
1 (0.05%)

914 (1.20%)
47 (0.06%)
436 (0.57%)
122 (0.16%)
4 (0.01%)
10 (0.01%)

0.194
0.387
0.953
0.589
>0.999
0.262

1 (0.05%)
0 (0.00%)
2 (0.09%)
0 (0.00%)

67 (0.09%)
96 (0.13%)
128 (0.17%)
30 (0.04%)

>0.999
0.118
0.590
>0.999

2 (0.09%)
0 (0.00%)

130 (0.17%)
1 (0.00%)

0.591
>0.999

*Comparisons for pooled major medical complications, and acute stroke, were
determined using chi-squared test. The other comparisons were made using
Fisher’s exact test.

complications following oCTR are consistent with previous literature for minor hand surgeries. Lipira et al found
the risk of myocardial infarction, pulmonary embolism,
shock, stroke, hemorrhage, or nerve injury for outpatient hand surgery to each be less than 0.1%.24 Although
an OR comparison group was not studied, Bismil et al
additionally found no intraoperative complications in
their analysis of 1000 consecutive cases of various upper
limb orthopedic surgeries utilizing a safe, efficient,
and effective one-stop (patient seen and treated in one
appointment) wide-awake (local anesthesia only) hand
surgery service they developed as an alternative to the OR
surgical setting.28
Secondary study findings pertain to the risk of pooled
surgical site and wound complications, which were infrequent and similar between PR and OR settings. Our
observed risk of wound complications, ranging from
0.56% in the PR group to 0.81% for the OR, is consistent with the 0.32% infection rate observed by Werner

et al among over 450,000 CTR surgeries performed.29 A
breakdown by surgery setting or anesthesia type was not
provided, and the authors excluded patients undergoing simultaneous distal radius ORIF, but did not exclude
other concomitant procedures. Our study also found a
0.56% surgical site infection rate for the PR group and
0.81% for the OR group, consistent with Lipira et al’s
reported 1.1% in 10,646 patients who underwent surgical
procedures of the hand or wrist24 and Tosti et al’s 0.66%
after 600 consecutive elective soft tissue hand surgeries.30
Maliha et al found no difference in intraoperative and
postoperative complication rates, infection rates, wound
healing complications, or recurrences for patients who
underwent trigger finger release in an OR versus PR settings.8 However, this study was limited in statistical power,
with only 39 PR and 37 OR patients, which precludes
forming statistically-sound, firm conclusions about potential differences in these rare complications. It is important to note that although we found a significantly lower
rate of wound disruption in the PR group (0.05% versus
0.31%), this unadjusted finding did not account for the
higher rate of comorbidities in the OR group, including
diabetes and obesity, and in terms of the main secondary
outcome (pooled complication risk), there was no difference between PR and OR groups.
Lastly, we found low rates of pooled iatrogenic complications in our cohorts. Specifically, the pooled iatrogenic
complication rate was 0.09% for the OR group and 0.05%
for the PR group, with no difference between surgical settings. Due to the rarity of these complications, we cannot
draw strong conclusions, other than the observation that
these issues are infrequent in general following oCTR
in both surgical settings. This finding is congruent with
prior literature that observed no iatrogenic complications among 1404 procedure room surgical encounters31
and absence of such complications in two independent
smaller studies.8,28 This finding is additionally supported
by Lipira et al, who detailed a nerve injury rate of less than

Table 3. Multivariable Logistic Regression Model for Pooled Major Medical Complication Risk
95% Wald Confidence Limits
Variable*†
Surgical setting (PR versus OR)
Elixhauser comorbidity index variables
Anemia
Rheumatoid arthritis/collagen vascular disease
Chronic pulmonary disease
Diabetes
Drug abuse
Hypertension
Neurologic disorders
Psychological disorders/psychosis
Hypothyroidism
Sex (men versus women)
Age category (versus 18–39)
40–49
50–59
60+

Coefficient

Upper Limit

Lower Limit

P

0.84
—
3.33
2.21
2.39
2.16
2.08
1.80
2.16
1.42
1.46
1.42
—
1.95
3.25
4.81

0.53
—
2.46
1.62
1.93
1.85
1.19
1.56
1.46
1.05
1.10
1.24
—
1.36
2.32
3.40

1.33
—
4.51
3.02
2.98
2.52
3.64
2.08
3.19
1.93
1.92
1.62
—
2.81
4.56
6.81

0.450
—
<0.0001
<0.0001
<0.0001
<0.0001
0.010
<0.0001
0.000
0.024
0.008
<0.0001
—
<0.0001
<0.0001
<0.0001

*Note that the following additional variables were included in the model but were eliminated through a backward term selection method: alcohol abuse, obesity,
solid tumor without metastasis, and smoking. Rural (versus urban) residence, region, and insurance type were also nonsignificant.
†Note that the following Elixhauser comorbidity variables were not analyzed in this model due to insignificance in univariate analysis (P > 0.20) or due to counts <
5: AIDS, chronic blood loss anemia, congestive heart failure, coagulopathy, depression, liver disease, lymphoma, fluid and electrolyte disorders, metastatic cancer,
paralysis, peripheral vascular disease, pulmonary circulation disease, renal failure, valvular disease, and weight loss.
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Table 4. Unadjusted Risk of Surgical Site Complications
PR
(n = 2134)
Pooled surgical site
complications
12 (0.56%)
Surgical site infection
10 (0.47%)
Surgical site wound
1 (0.05%)
disruption
Surgical site seroma
0 (0.00%)
Surgical site hematoma
1 (0.05%)
Surgical site nonhealing
1 (0.05%)
wound
Hemorrhage
0 (0.00%)
complicating a procedure

Table 6. Unadjusted Rates of Iatrogenic Surgical
Complication Risk

OR
(n = 76,216)

P*

616 (0.81%)
303 (0.40%)
235 (0.31%)

0.209
0.608
0.024

28 (0.04%) >0.999
25 (0.03%) 0.512
87 (0.11%) 0.735

Pooled iatrogenic
complications
New nerve injury
New blood vessel
injury
New tendon injury
Iatrogenic injury

PR (n = 2060)

OR (n = 73925)

1 (0.05%)

71 (0.09%)

>0.999

1 (0.05%)
0 (0.00%)

41 (0.05%)
8 (0.01%)

>0.999
>0.999

0 (0.00%)
1 (0.05%)

22 (0.03%)
30 (0.04%)

>0.999
0.575

P*

*Comparisons were made using Fisher’s exact test.

24 (0.03%) >0.999

*Comparisons for pooled surgical site complications, and surgical site
infection, were determined using Chi-squared test. The other comparisons
were made using Fisher’s Exact Test.

0.1% in both surgical settings for their cohort of 10,646
patients who had undergone surgical procedures of the
hand or wrist in the inpatient or outpatient setting.24
Our study contains several limitations that deserve
mention. Our power calculation utilized the observed
ratio of OR to PR cases (35.7:1) to achieve 80% power at
a 95% confidence level, which allowed us to calculate the
number of patients needed in each surgical setting to discriminate a difference of less than 0.75% for major medical complications on the two-tailed two-proportion test.
We felt that we powered our study to a clinically meaningful low threshold, but the determination of the most
appropriate threshold is somewhat subjective. Our study
had potential for coding errors given the administrative
database that was utilized to identify our cohort. The
MarketScan database is limited in scope and is not comprehensive of all data variables. Due to the claims nature
of the database, it is possible that we are under-capturing
minor complications that are not tied to reimbursement.
However, major complications that require re-operation
and are thus tied to reimbursement are likely to be coded
more accurately. We did not collect data regarding local

anesthesia complications because we were unable to
achieve this level of granularity with this database study,
although this has been noted to be very rare or not
reported in large series of WALANT cases.10,32 The generalizability of our study to older or more socially deprived
patient populations is unclear, given our utilization of
the MarketScan database, which solely comprises commercially insured patients younger than 65 years of age.
Our study only looked at complications within a 90-day
postoperative period. However, the NSQIP database33
only looks at 30 days postoperatively for complications;
so we feel our 90-day period is fairly comprehensive, but
it is possible that later complications or revisions could
be missed by our analysis. We also excluded a large number of patients. It is possible that these exclusions could
have an impact on the results, but we do not know if
those excluded differ from those included in our study.
The interpretation of our results is somewhat limited in
regard to commenting on what extent the surgical setting
versus the anesthesia type impacted the observed similar
safety profile and complications among the two patient
groups, as the PR setting is linked to local-only anesthesia. Lastly, the rarity of iatrogenic surgical complications
precluded our ability to perform a multivariable analysis
to control for demographics and comorbidities among
cohorts.

Table 5. Multivariable Logistic Regression Model for Pooled Surgical Site Complication Risk
95% Wald Confidence Limits
Variable*†
Surgical setting (PR versus OR)
Elixhauser comorbidity index variables
Chronic pulmonary disease
Diabetes
Obesity
Psychological disorders/psychosis
Solid tumor
Region (versus South)
North central
North east
West
Gender (men versus women)
Smoking

Coefficient

Upper Limit

Lower Limit

P

0.69
—
1.67
1.64
1.53
1.64
2.60
—
0.82
0.85
1.17
1.32
1.36

0.38
—
1.21
1.33
1.23
1.15
1.57
—
0.68
0.67
0.92
1.13
1.10

1.22
—
2.30
2.03
1.89
2.33
4.30
—
0.98
1.08
1.51
1.56
1.69

0.200
—
0.002
<0.0001
0.000
0.007
0.000
—
0.032
0.173
0.205
0.001
0.004

*Note that the following additional variables were included in the model but were eliminated through a backward term selection method: age, depression, hypertension, hypothyroidism, and neurologic disorders.
†Note that the following Elixhauser comorbidity variables were not analyzed in this model due to insignificance in univariate analysis (P > 0.20) or due to counts <
5: AIDS, chronic blood loss anemia, congestive heart failure, coagulopathy, depression, liver disease, lymphoma, fluid and electrolyte disorders, metastatic cancer,
paralysis, peripheral vascular disease, pulmonary circulation disease, renal failure, valvular disease, and weight loss. Rural (versus urban) residence and insurance
type were also nonsignificant.
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In conclusion, our findings support a similar safety profile for OR and PR surgical settings for patients who underwent oCTR. Rates of pooled major medical complications
were low and similar following oCTR performed in either
setting, as were pooled surgical site/wound complications
and iatrogenic complications. In light of these findings supporting a similar safety profile, prior studies illustrating a
substantial cost reduction associated with use of the PR setting for oCTR when compared with the OR,3–13 and similar
clinical outcomes following oCTR performed in PR and
OR settings,33 we conclude that the value of utilizing the PR
setting for oCTR is greater than that of the OR.
Nikolas H. Kazmers, MD, MSE
590 Wakara Way
Salt Lake City, UT 84108
E-mail: nkazmers@gmail.com
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